Latest News and Press Releases
Want to stay updated on the latest news?
- 
                            
Nurix presents new data from bexobrutideg Ph 1a/1b clinical trial in patients with r/r CLL and updates in patients with WM at #ASH25
 - 
                            
Validic today announced its participation at HLTH 2025, where the company will showcase its EHR-integrated solution, and comprehensive wearable data APIs.
 - 
                            
Epista Life Science initiates one of the industry's largest clinical data remediation programs, spanning 800+ studies and 4M documents for global pharma.
 - 
                            
VIENNA, Va., Aug. 25, 2025 (GLOBE NEWSWIRE) -- The Sequoia Project, a non-profit and trusted advocate for nationwide health IT interoperability, in partnership with the American Health Information...
 - 
                            
Validic launches a generative AI solution designed to help healthcare organizations transform personal health data into actionable insights.
 - 
                            
Positive nebokitug PSC Phase 2 data was presented in an oral session at BSG Live’25, the scientific meeting of the British Society for Gastroenterology.
 - 
                            
Heat-triggered release mechanism unequivocally confirmedFavorable safety profile with good tolerability Signs of encouraging clinical activity in heavily pre-treated patients including meaningful...
 - 
                            
Abvance presents first-in-human data on insulin-glucagon co-dosing in T1D, demonstrating a novel approach to help prevent hypoglycemia
 - 
                            
Complete response achieved in CLL; overall objective response rate of 80.9% in CLL patients and 84.2% in patients with WM Bexobrutideg was well tolerated with no new safety signals observed with...
 - 
                            
WILMETTE, Ill., May 07, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients with...